|
|
Prepublished online as a Blood First Edition Paper on May 1, 2003; DOI 10.1182/blood-2002-10-3293.
 Previous Article | Table of Contents | Next Article 
Blood, 15 September 2003, Vol. 102, No. 6, pp. 1951-1958
CHEMOKINES
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice
Katia Beider,
Arnon Nagler,
Ori Wald,
Suzanna Franitza,
Michal Dagan-Berger,
Hanna Wald,
Hilla Giladi,
Stefan Brocke,
Jacob Hanna,
Ofer Mandelboim,
Merav Darash-Yahana,
Eithan Galun, and
Amnon Peled
From the Gene Therapy Institute, Hadassah University Hospital, Jerusalem, Israel; the Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; the Department of Pathology, Hebrew University Hadassah Medical School, Jerusalem, Israel; and the Lautenberg Center for General and Tumor Immunology Oncology, Hadassah Medical School, Jerusalem, Israel.
Human natural killer (NK) and NK T cells play an important role in allogeneic bone marrow (BM) transplantation and graft-versus-leukemia (GVL) effect. The mechanisms by which these cells home to the BM and spleen are not well understood. Here we show that treatment of these cells with pertussis toxin and neutralizing antibodies to the chemokine receptor CXCR4 inhibited homing of the cells to the BM, but not the spleen, of NOD/SCID mice. The retention of NK and NK T cells within the spleen and BM was dependent on G i signaling and CXCR4 function. The chemokine receptors CXCR4 and CXCR3 are expressed predominantly on the cell surface of NK T cells. Following activation with interleukin-2 (IL-2), the levels of CXCR4 on NK and NK T cells decreased significantly. Treatment of cells with IL-2 inhibited their migration in response to CXCL12 and their homing and retention in the BM and spleen of NOD/SCID mice. In contrast to CXCR4, the expression levels of the chemokine receptor CXCR3 and the migration of cells in response to CXCL9 and CXCL10 increased after IL-2 treatment. Thus, down-regulation of CXCR4 and up-regulation of CXCR3 may direct the trafficking of cells to the site of inflammation, rather than to hematopoietic organs, and therefore may limit their alloreactive potential.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. N. Jenne, A. Enders, R. Rivera, S. R. Watson, A. J. Bankovich, J. P. Pereira, Y. Xu, C. M. Roots, J. N. Beilke, A. Banerjee, et al.
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow
J. Exp. Med.,
October 26, 2009;
206(11):
2469 - 2481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Busuttil, S. S. Weigt, M. P. Keane, Y. Y. Xue, V. Palchevskiy, M. D. Burdick, C. Huang, D. A. Zisman, M. Fishbein, J. P. Lynch III, et al.
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
Eur. Respir. J.,
September 1, 2009;
34(3):
676 - 686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Keeley, B. Mehrad, and R. M. Strieter
Chemokines as Mediators of Neovascularization
Arterioscler Thromb Vasc Biol,
November 1, 2008;
28(11):
1928 - 1936.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Waiczies, I. Bendix, T. Prozorovski, M. Ratner, I. Nazarenko, C. F. Pfueller, A. U. Brandt, J. Herz, S. Brocke, O. Ullrich, et al.
Geranylgeranylation but Not GTP Loading Determines Rho Migratory Function in T Cells
J. Immunol.,
November 1, 2007;
179(9):
6024 - 6032.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Dagan-Berger, R. Feniger-Barish, S. Avniel, H. Wald, E. Galun, V. Grabovsky, R. Alon, A. Nagler, A. Ben-Baruch, and A. Peled
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11
Blood,
May 15, 2006;
107(10):
3821 - 3831.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Wald, I. D. Weiss, H. Wald, H. Shoham, Y. Bar-Shavit, K. Beider, E. Galun, L. Weiss, L. Flaishon, I. Shachar, et al.
IFN-{gamma} Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs.
J. Immunol.,
April 15, 2006;
176(8):
4716 - 4729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Pan, M. D. Burdick, J. A. Belperio, Y. Y. Xue, C. Gerard, S. Sharma, S. M. Dubinett, and R. M. Strieter
CXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis
J. Immunol.,
February 1, 2006;
176(3):
1456 - 1464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Hanna, H. Mussaffi, G. Steuer, S. Hanna, M. Deeb, H. Blau, T. I. Arnon, N. Weizman, and O. Mandelboim
Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency
Blood,
November 15, 2005;
106(10):
3465 - 3473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Jeeninga, B. Jan, B. van der Linden, H. van den Berg, and B. Berkhout
Construction of a Minimal HIV-1 Variant that Selectively Replicates in Leukemic Derived T-Cell Lines: Towards a New Virotherapy Approach
Cancer Res.,
April 15, 2005;
65(8):
3347 - 3355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tao, L. Shangwu, W. Qun, L. Yan, J. Wei, L. Junyan, G. Feili, J. Boquan, and T. Jinquan
CD226 Expression Deficiency Causes High Sensitivity to Apoptosis in NK T Cells from Patients with Systemic Lupus Erythematosus
J. Immunol.,
February 1, 2005;
174(3):
1281 - 1290.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
